Antibiotics, the cornerstone of modern medicine, have been pivotal in combating infectious diseases. However, their irrational use has led to a global health crisis of antibiotic resistance. This article aims to guide medical professionals towards rational antibiotic use, promoting patient health and combating antibiotic resistance.
Antibiotic resistance occurs when bacteria change in response to the use of antibiotics, making treatments ineffective and infections harder to control. This resistance stems from overuse and misuse of antibiotics, often driven by poor prescription practices, self-medication, and non-compliance to treatment regimens.
Rational antibiotic use involves prescribing the right antibiotic, at the right dose, at the right time, and for the right duration. It necessitates a deep understanding of pharmacokinetics, pharmacodynamics, and the local antibiogram. Clinicians should also consider patient-specific factors such as age, renal function, and potential drug interactions.
Diagnostic stewardship plays a crucial role in rational antibiotic use. It involves using diagnostic tests to guide antibiotic therapy, thereby reducing unnecessary antibiotic exposure. Rapid diagnostic tests, culture and sensitivity tests, and molecular tests can help identify the pathogen and its antibiotic susceptibility, facilitating targeted therapy.
Antibiotic stewardship programs (ASPs) aim to optimize antibiotic use within healthcare settings. They involve coordinated interventions designed to improve and measure the appropriate use of antibiotics by promoting the selection of the optimal antibiotic regimen. ASPs have been shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.
Rational use of antibiotics is an urgent global necessity. By adhering to the principles of rational use, employing diagnostic stewardship, and implementing antibiotic stewardship programs, medical professionals can play a significant role in preserving the efficacy of antibiotics, promoting patient health, and combating antibiotic resistance.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation